Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 23, 2026

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker
07:47

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker

Published on: September 15, 2023

Transcriptomics-based multi-omics approach for optimizing risk stratification in acute myeloid leukemia.

Yang Yang1,2,3, Lun Yan1,2,3, Jianjun Fang1,2,3

  • 1Medical Center of Hematology, Xinqiao Hospital of Army Medical University, Chongqing, 400037 China.

Blood Science (Baltimore, Md.)
|June 22, 2026
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reduced-intensity conditioning therapy with fludarabine, idarubicin, busulfan and cytarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia and myelodysplastic syndrome.

Leukemia research·2013
Same author

Effects of 3, 5, 3'-triiodothyronine (t3) and follicle stimulating hormone on apoptosis and proliferation of rat ovarian granulosa cells.

The Chinese journal of physiology·2013
Same author

Cardiogenic shock from acute ST-segment elevation myocardial infarction induced by severe multivessel coronary vasospasm.

European heart journal·2013
Same author

[Comparative study on effects of electroacupuncture stimulation of Shenmen (HT 7) and Taiyuan (LU 9) on P 300 of event-related potentials and brain electrical activity mapping in healthy young adults].

Zhen ci yan jiu = Acupuncture research·2013
Same author

MiR-215 modulates gastric cancer cell proliferation by targeting RB1.

Cancer letters·2013
Same author

Low glucose utilization and neurodegenerative changes caused by sodium fluoride exposure in rat's developmental brain.

Neuromolecular medicine·2013
Same journal

Application value and challenges associated with plasma cell-free DNA metagenomic sequencing technology in the diagnosis of infections in patients with hematological disorders.

Blood science (Baltimore, Md.)·2026
Same journal

Refining favorable-risk classification in pediatric <i>RUNX1::RUNX1T1</i> acute myeloid leukemia.

Blood science (Baltimore, Md.)·2026
Same journal

Febrile neutropenia adversely affects chemomobilization outcomes in patients with multiple myeloma and increases risk for post-transplant infection in those with lymphoma: real-world multicenter data.

Blood science (Baltimore, Md.)·2026
Same journal

ABCB6 promotes multidrug resistance in leukemia by mediating drug efflux.

Blood science (Baltimore, Md.)·2026
Same journal

Enforced BATF expression via clinically approved LNPs enhances adoptive T-cell therapies.

Blood science (Baltimore, Md.)·2026
Same journal

The role of <i>MXRA7</i> in bone marrow senescence involves macrophage polarization and microenvironment remodeling.

Blood science (Baltimore, Md.)·2026
See all related articles
This summary is machine-generated.

This study introduces a new transcriptomics-based assay for molecular subtyping and risk stratification in acute myeloid leukemia (AML). This approach enhances diagnostic accuracy and prognostic prediction for AML patients.

Area of Science:

  • Hematology
  • Molecular Biology
  • Oncology

Background:

  • Acute myeloid leukemia (AML) is a cancer of myeloid cells.
  • Current molecular subtyping relies on DNA-based methods.
  • RNA sequencing (RNA-seq) offers potential for improved AML diagnostics.

Purpose of the Study:

  • To identify transcriptomic signatures for molecular genotyping in AML.
  • To develop a transcriptomics-based assay for risk stratification.
  • To enhance prognostic prediction and therapeutic selection in AML.

Main Methods:

  • Analyzed transcriptomic data from 125 AML patients (excluding PML::RARA fusions).
  • Developed a two-step diagnostic assay based on transcriptomic expression.
  • Integrated transcriptomic data with genetic mutations and fusion genes.
Keywords:
Acute myeloid leukemiaOlfactory receptorsRNA sequencing

Related Experiment Videos

Last Updated: Jun 23, 2026

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker
07:47

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker

Published on: September 15, 2023

Main Results:

  • Identified novel transcriptomic signatures for AML subtyping.
  • Established a transcriptomics-based assay for risk stratification.
  • Demonstrated potential for improved outcome prediction in AML.

Conclusions:

  • Transcriptome-based multi-omics prediction models can improve AML risk stratification.
  • This approach enhances diagnostic confidence and accuracy.
  • Further exploration can refine prognostic prediction and therapeutic strategies for AML.